Surface modification of RGD-liposomes for selective drug delivery to monocytes/neutrophils in brain.
In the present study, RGD peptide was coupled with ferulic acid (FA) liposomes for binding to monocytes and neutrophils in peripheral blood for brain targeting in response to leukocyte recruitment. Cholesterol (Ch) was esterified with succinic anhydride to introduce a carboxylic end group (Ch-COOH). Soybean phosphatidylcholine, cholesterol and Ch-COOH were in a molar ratio of 1 : 0.23 : 0.05. FA was loaded into liposomes with 80.2+/-5.2% entrapment efficiency (EE) using a calcium acetate gradient method since it was difficult to load FA by other methods. RGD peptide was a novel compound coupled with Ch-COOH via carbodiimide and N-hydroxysulfosuccinimide. The results of the in vitro flow cytometric study showed that RGD conjugation liposomes (RGD-liposomes) could bind to monocytes/neutrophils efficiently. The rats were subjected to intrastriatal microinjections of 100 microl of human recombinant IL-1beta to produce brain inflammation and subsequently sacrificed after 15, 30, 60 and 120 min of administration of three formulations (FA solution, FA liposome, RGD-coated FA liposome). The body distribution results showed that RGD-liposomes could be directed to the target site, i.e. the brain, by cell selectivity in case of an inflammatory response. For RGD coated liposomes, the concentration of FA in brain was 6-fold higher than that of FA solution and 3-fold higher than that of uncoated liposomes. MTT assay and flow cytometry were used in the pharmacodynamic studies where it was found that FA liposomes exhibited greater antioxidant activity to FA solution on U937 cell.
Qin
Jing
J
Department of Pharmaceutics, School of Pharmacy, Shenyang Pharmaceutical University, Shenyang, Liaoning, P.R. China.
Chen
DaWei
D
Hu
HaiYang
H
Cui
Qiao
Q
Qiao
MingXi
M
Chen
BaoYu
B
D000818:Animals; D001921:Brain / Q000166:cytology* / Q000378:metabolism*; D002470:Cell Survival / Q000187:drug effects; D002851:Chromatography, High Pressure Liquid; D020285:Cryoelectron Microscopy; D004337:Drug Carriers; D016503:Drug Delivery Systems; D005227:Fatty Acids / Q000032:analysis; D005614:Freeze Fracturing; D007202:Indicators and Reagents; D007249:Inflammation / Q000473:pathology; D008081:Liposomes / Q000737:chemistry*; D008297:Male; D008564:Membrane Potentials / Q000187:drug effects; D009000:Monocytes / Q000737:chemistry*; D009504:Neutrophils / Q000737:chemistry*; D009842:Oligopeptides / Q000008:administration & dosage* / Q000737:chemistry / Q000493:pharmacokinetics; D018384:Oxidative Stress; D010316:Particle Size; D051381:Rats; D017208:Rats, Wistar; D013056:Spectrophotometry, Ultraviolet; D013499:Surface Properties; D014018:Tissue Distribution
D004337:Drug Carriers; D005227:Fatty Acids; D007202:Indicators and Reagents; D008081:Liposomes; D009842:Oligopeptides; C047981:arginyl-glycyl-aspartic acid